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A furosemide–isonicotinamide cocrystal: an
investigation of properties and extensive
structural disorder†
Hannah E. Kerr,a Lorna K. Softley,a Kuthuru Suresh,c Ashwini Nangia,*c
Paul Hodgkinson*a and Ivana Radosavljevic Evans*ab
Furosemide is a loop diuretic drug marketed in solid form which suffers from low solubility and low
permeability. The pharmaceutically relevant properties of a recently described furosemide–isonicotinamide
2 : 1 cocrystal (2FS–INA) were investigated and compared with those of other known furosemide cocrystals.
The intrinsic dissolution rate of 2FS–INA was found to be very similar to that of commercial FS, while its
equilibrium solubility was 5.6 times higher than that of pure FS. The extensive structural disorder in 2FS–
INA observed by diffraction methods was also investigated by variable-temperature solid-state NMR in
conjunction with first principles calculations. 15N NMR confirmed the absence of proton disorder in the
short OH⋯N hydrogen bond. The disordered sulphonamide group was found to be dynamic by variable
temperature 2H experiments, involving fast exchange of the sulphonamide NH2 protons combined with a
rotation of the whole sulphonamide group about the C–S bond. The disorder of the furan rings of both the
unique furosemide molecules was also found to be dynamic by 13C experiments, with approximately the
same activation barrier for both rings.
Introduction
Furosemide (Fig. 1) is a loop diuretic used to treat edema and
hypertension linked to congestive heart failure, cirrhosis of
the liver and renal disease, by preventing reabsorption of
unneeded water back into the body.1 The drug is available in
solid tablet form to be taken orally, or as a solution to be
injected into the body.2 The orally administered form of FS is
a BCS class IV drug, having low aqueous solubility (6 mg L−1
in water) and low permeability.3 The absorption of FS is site-
specific to the stomach and small intestine where it has low-
est solubility, thus bioavailability of the drug is limited, as
well as being widely variable between individuals. High doses
or prolonged use of the drug can lead to fluid and electrolyte
imbalance which can provoke headaches, cramping, thirst
and weakness.4 Therefore development of this drug to
improve its solubility is important to be able to minimise the
dose size in order to reduce side effects. The poor solubility
of FS is reportedly linked to strong intra- and inter- molecular
hydrogen bonding in the pure crystal, resisting facile solva-
tion, and its weakly acidic nature.5
There have been numerous successful attempts to improve
the properties of FS. Mesoporous materials, such as SBA-15
containing silica walls with large pores, have been used as
drug delivery systems to improve the release of FS in site-
specific areas. The large surface area resulting from the pores
allow facile adsorption of FS onto its surface via weak interac-
tions (allowing rapid drug release), while the silanol groups
provide hydrophilic character to carry and deliver the drug in
aqueous media.5 Alternatively, surfactant-based methods
have been used in self-Ĳmicro)emulsifying formulations which
contain a mixture of oil, surfactant and hydrophilic cofactant.
The formulation is able to form an oil/water emulsion in the
stomach or intestine. A solid form of the formulation, loaded
with FS, has been seen to improve both permeability and sol-
ubility of the drug.6 Most recently, improved solubility has
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been achieved in Na and K salts of FS.7 Finally, numerous
cocrystals of FS with a range of coformers, as well as cocrystal
polymorphs, hydrates and solvates have been reported.3,8–12
The FS molecule contains potential hydrogen bond donor
and acceptor groups: COOH, NH and SO2NH2, and additional
potential for halogen bonding from chlorine. The groups
COOH and SO2NH2 are known to give robust heterosynthons
via O–H⋯O and N–H⋯O hydrogen bonds, forming a wide
range of stable supramolecular structures. The propensity for
hydrogen bonding enables FS to exist in different polymor-
phic forms, of which three have been reported.13 Polymor-
phism is a result of the combination of functional groups to
form different synthons, as well as the conformational flexi-
bility about the sulphonamide and furan torsion angles.
Higher dissolution rates were observed with the metastable
polymorphs, but their use as a marketable drug is limited by
their tendency to convert to the stable polymorph during
experiments or storage.13
To date, six FS cocrystals (not including hydrates or sol-
vates) with a range of coformers have been prepared and fully
structurally characterised.3,8,12 In all cases studied, solubility
was improved over pure FS. The only crystal form for which
the pharmacologically relevant properties have not been
reported is the 2FS–INA cocrystal, which is reported here.
The coformers and synthons relevant to the FS cocrystal
structures are summarised in Fig. 2 and Table 1. FS–CAF and
FS–CYT crystallise in the triclinic space group P1¯. FS–CYT is
distinct from the other structures due to the occurrence of
proton transfer in synthon N to form the strong, electrostatic
hydrogen bond COO−⋯+HN, and so is more appropriately
described as a salt. There is no proton transfer in FS–CAF;
hierarchical hydrogen bonding means that synthon E is the
strongest interaction. The three pyridine carboxamide-based
cocrystals (FS–NA, FS–INA and 2FS–INA) all crystallise in the
monoclinic space group P21/n, but have distinctly different
structures, despite sharing the same functional groups for
potential hydrogen bonding. Synthon E is common to all
three cocrystals, but the remaining synthons differ as a result
of isomeric change of the coformer or stoichiometry. The
molecules in FS–PABA form homodimers via synthon A,
which are connected by a weak interaction via synthon K.
The structural flexibility to which FS owes its rich supra-
molecular chemistry can also manifest itself as crystallo-
graphic disorder, as evidenced in a number of the known
solid forms. The crystal structure of FS form II possesses one
unique FS molecule with the furan ring disordered over two
positions (differing by an angle of 172° between the ring
planes) with 0.75 : 0.25 occupancies at 298 K. The structure of
form I was initially solved with similar disorder, but further
analysis revealed the true structure to have a doubled unit
cell containing two FS molecules that differed only in the
furan ring orientation.13 Several cocrystals of FS also show
ring disorder.14–16 For example, the structure of FS–CAF
was solved at 100 K with the ring disordered over two posi-
tions (differing by an angle of 175° between the ring planes)
with equal occupancy.15 Disorder of the whole SO2NH2
sulphonamide group is not commonly observed in FS crystal
forms, presumably because this group is usually involved in
hydrogen bonding networks, as evidenced by a systematic
study of aromatic primary sulphonamide pyridine-N-oxides
synthons.14 It has been noted, however, that the NH2 of the
sulphonamide can adopt different orientations through rota-
tions about the S–N bond in FS13 and FS-containing
cocrystals,9 indicating that there is conformational flexibility.
The recently reported 2FS–INA cocrystal exhibits a particu-
larly complex disorder, which affects both crystallographically
unique FS molecules (FS1 and FS2, see Fig. 3), both the
sulphonamide group and the furan ring, and potentially a
short strong hydrogen bond.8 This single crystal X-ray diffrac-
tion study was carried out at 120 K. The sulphonamide group
on FS1 is disordered over two positions with 0.51Ĳ1) : 0.49Ĳ1)
occupancies, differing by a 32° rotation about the C–S bond.
The furan ring on FS2 was modelled using split atomic sites,
as disordered over two positions with 0.67Ĳ2) : 0.33Ĳ2) occu-
pancies. The furan ring on FS1 could be modelled satisfacto-
rily using single atomic sites, albeit with the anisotropic
atomic displacement parameters somewhat elongated in a
direction perpendicular to the ring. A further interesting
feature of the 2FS–INA structure is the presence of a short
strong hydrogen bond (SSHB) between the COOH on FS1 and
the ring nitrogen of INA (donor acceptor distance, rOH–N =
2.546 Å), similar in length to the NH⋯O SSHB found in
3,5-pyridinedicarboxylic acid, which showed temperature-
dependent proton migration across the SSHB,17,18 demon-
strating the potential for proton dynamics in 2FS–INA.
Previous X-ray diffraction studies provided an average
structural picture for 2FS–INA at a single temperature. Solid-
state NMR is highly complementary to X-ray diffraction, par-
ticularly for characterising polymorphic behaviour and
Fig. 2 The coformers in structurally characterised FS cocrystals and
the synthons present in FS cocrystals.
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disorder in pharmaceutically relevant materials.19–21 In par-
ticular, NMR relaxation times and 2H NMR spectra are very
sensitive to dynamic processes.22,23 Here we use 13C, 2H and
15N solid-state NMR, supported by DFT calculations, to eluci-
date the nature of three different aspects of structural disor-
der in this furosemide crystal form.
Experimental
Synthesis
The polycrystalline sample of the 2FS–INA cocrystal was pre-
pared by a solvent-assisted mechanochemical route. Stoichio-
metric quantities of FS (264 mg, 0.800 mmol) and INA (48.8
mg, 0.400 mmol) were weighed out and ground in a mortar
and pestle, with dropwise addition of a total of 2.5 mL of ace-
tone over 30 minutes of grinding. The phase purity of the
material prepared was confirmed by powder X-ray diffraction
(PXRD). XRD data were collected on a Bruker D8 ADVANCE
diffractometer (Cu Kα1,2 radiation) and a LynxEye detector, in
a 2θ range between 2° and 60° and using a step size of
0.014°. Data analysis was carried out using Topas-Academic
software.24 An extensive characterisation (including PXRD,
solid-state 13C NMR spectra of the individual components
and the product, as well as differential scanning calorimetry
data), showing that this method produces a single phase
2FS–INA cocrystal, has been reported previously.8
Dissolution and solubility experiments
Intrinsic dissolution rate (IDR) and solubility tests were car-
ried out on the 2FS–INA cocrystal. Due to the low solubility of
FS in aqueous media, the tests were carried out in 10% etha-
nol–water. The absorbance of known amounts of 2FS–INA
dissolved in a 10% v/v ethanol–water medium were measured
at the given λmax 329 nm on a Thermo Scientific Evolution
300 UV-vis spectrometer (Thermo Scientific, Waltham, MA),
and these absorbance values used to obtain the molar extinc-
tion coefficient for 2FS–INA in solution. The IDR experiments
were carried out using a United States Pharmacopeia (USP)
certified Electrolab TDT-08L dissolution tester (Electrolab,
Mumbai, MH). Dissolution experiments were performed for 6
hours in 10% ethanol–water medium at 37 °C. For IDR mea-
surements, 100 mg of the compound was taken in the intrin-
sic attachment and compressed to a 0.5 cm2 disc using a
hydraulic press at pressure of 4.0 ton inch−2 for 5 min. The
intrinsic attachment was placed in a jar of 500 mL 10% etha-
nol–water medium preheated to 37 °C and rotated at 150
rpm. 5 mL aliquots were collected at specific time intervals
and concentration of the aliquots were determined with
appropriate dilutions from the predetermined standard
curves of the respective compounds. The effective IDR (mass
dissolved per unit area and time) was calculated for each
interval between measurement points and averaged. The
equilibrium solubility 2FS–INA was measured using the
Higuchi and Connor method.25 An excess amount of the sam-
ple was added to 5 mL of 10% ethanol–water medium. The
supersaturated solution was stirred at 300 rpm using a mag-
netic stirrer at 30 °C. After 24 h, the suspension was filtered
through Whatmann 0.45 μm syringe filter. The identity of the
undissolved material after the dissolution and equilibrium
solubility experiments was ascertained by PXRD.
Solid-state NMR
High-resolution solid-state NMR spectra were obtained using
a Bruker Avance III HD spectrometer operating at 125.67
MHz for 13C and 76.71 MHz for 2H with a 4 mm (rotor o.d.)
magic angle spinning (MAS) probe and 50.64 MHz for 15N
with a 5 mm (rotor o.d.) probe. 15N spectra were recorded at
ambient probe temperature, while 13C and 2H spectra were
Table 1 Summary of the synthons found in FS cocrystalsa
Cocrystal A B C D E F G H I J K L M N O
FS–CAFb * * *
FS–CYTb * * * *
FS–NAc * * *
FS–INAc * * * *
2FS–INAc * * * *
FS–PABAc * * *
a From the structures reported in ref. 13. b From the structures reported in ref. 3. c Taken from Table 6 in ref. 8.
Fig. 3 The asymmetric unit of 2FS–INA with the major occupied furan
ring and sulphonamide positions drawn as free atoms. The SSHB is
shown by the dashed red line and with hydrogen atoms are removed
for clarity except for those on the carboxylic acids. Thermal ellipsoids
are shown at the 50% probability level. FS site numbering follows that
of ref. 13 with labels followed by 1 or 2 to distinguish FS1 and FS2. A
trailing apostrophe identifies INA sites.
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recorded at temperatures between 80 °C and −70 °C. Note
that these were set temperatures and, unless stated other-
wise, do not include sample heating under MAS, which was
estimated to be +10 °C, +15 °C, and +5 °C for the 13C, 2H,
and 15N experiments respectively.
13C spectra were obtained using either direct excitation or
cross polarization (CP) with sideband suppression26 at 8 kHz
MAS (5 kHz MAS for spectra recorded below −20 °C), with a
recycle delay of 1 second in the direct excitation experiment
and 10–35 s in the CP experiments, depending on tempera-
ture. The contact time was 4 ms, acquiring over 48–180 tran-
sients. SPINAL64 with 78 kHz 1H nutation rate was used for
heteronuclear decoupling. Spectra were referenced by setting
the carbonyl resonance of replacement sample of α-glycine to
176.5 ppm. Dipolar dephasing spectra were acquired with a
dephasing delay of 80 μs. T1 relaxation times were measured
using a saturation-recovery scheme with 20 saturation pulses
separated by a delay of 10 ms at 8 kHz MAS, where the τ
delay was varied between 0.05–3 s in 25 steps. The peak
heights were picked using the Topspin T1/T2 module and
fitted to a single decaying exponential function in QtiPlot.27
1H-13C heteronuclear correlation spectra were recorded
using Lee–Goldburg CP with 109 kHz 1H nutation frequency
at 9.5 kHz MAS under the following conditions: recycle delay
10 s, contact times of 0.2 ms and 1 ms over 64t1 increments
using 128 transients. An FSLG pulse train was used for homo-
nuclear decoupling, while SPINAL64 was used for hetero-
nuclear decoupling during acquisition.
The 15N spectrum was recorded using CP and 8 kHz MAS
with the following conditions: 30 s recycle delay and 4 ms
contact time acquiring over 8640 transients. SPINAL64 with
55.6 kHz 1H nutation rate was used for heteronuclear
decoupling and the spectrum was referenced by setting the
signal from an external sample of 15N-labelled α-glycine to
−346.8 ppm. An apodization function corresponding to 60 Hz
Lorentzian line broadening was applied prior to Fourier
transformation.
Selective deuteration of the most labile protons was
achieved by storage in a D2O atmosphere for two weeks. The
samples were then kept sealed in a rotor to minimise
exchange with H2O in air.
2H spectra were recorded using a
simple pulse-acquire scheme without decoupling at 10 kHz
MAS, with a 1 s recycle delay and acquiring over 100 tran-
sients. T1 relaxation times were measured using a saturation-
recovery scheme with 20 saturation pulses separated by a
delay of 0.2 ms at 10 kHz MAS without decoupling, where the
τ delay was varied between 0.0001–2 s in 30 steps. The peak
heights were picked and fitted using the Topspin T1/T2 mod-
ule. Band shape analysis of the spinning sideband manifolds
was performed in GSim28/pNMRsim29 by simultaneously
fitting the peak linewidths (using a Lorentzian shape func-
tion) and quadrupolar parameters for each resolved site. Flat
baselines, necessary for fitting, were achieved using the
spline baseline correction in Topspin. Spectra were also
acquired from a sample that had been deuterated by shak-
ing in D2O for ten minutes followed by storage in a D2O
atmosphere, but the cocrystal was unstable in slurry in D2O
and the results were not reproducible (Fig. S6 of the ESI†).
Computational methods
First principles computations were carried out using the
GIPAW method implemented in CASTEP v6.0.30–32 In order
to carry out calculations on the disordered cocrystal, the pre-
viously reported crystal structure8 was split into four in which
one of each of the disordered groups' orientations (r1/r2
for the disordered ring and s1/s2 for the disordered
sulphonamide) was deleted, resulting in the four structures
r1s1, r1s2, r2s1 and r2s2. All calculations were performed
using the PBE functional33 using on-the-fly generated ultra-
soft pseudopotentials. Geometry optimisations were carried
out with the centre of mass fixed and a cut-off energy of 500
eV, with integrals taken over the Brillouin zone using a
Monkhorst–Pack grid with a k-point sample spacing of 0.1 Å−1
(1 k-point). All 316 atom positions were optimised with the
unit cell parameters fixed to the values determined by single
crystal XRD. The behaviour of the SSHB in 2FS–INA was prob-
lematic in the geometry optimisations, with the proton being
transferred in some of the calculations. Similar issues have
been found with other GGA functionals.34,35 To avoid this,
the proton was also fixed in position in the two problematic
optimisations: r1s2-f and r2s2-f. Hydrogen atom-only optimi-
sation was also carried out, but the maximum forces on the
heavy atoms were two orders of magnitude larger than opti-
misation involving all atom positions and the ordering of
predicted carbon chemical shift assignments was also found
to match poorly with experimental data. NMR calculations
used slightly tighter conditions with a cut-off energy of 600
eV and k-point sample spacing of 0.05 Å−1 (4 k-points) with
an offset of (0.25, 0.25, 0.25) to avoid sampling the gamma
point.
Results and discussion
IDR and solubility of 2FS–INA cocrystals
The Intrinsic Dissolution Rate (IDR) is a time-dependent
kinetic measurement of the rate of drug dissolution. The IDR
of the 2FS–INA cocrystal is 44 × 10−3 mg cm−2 min−1, indistin-
guishable within experimental uncertainty from that of com-
mercial FS (44 × 10−3 mg cm−2 min−1) over the 6 hour period
of the measurement. The dissolution curves for pure FS and
the 2FS–INA cocrystal, recorded over 6 hours, are shown in
Fig. S1 in the ESI.† PXRD of the undissolved material after
the IDR measurement confirmed cocrystal stability under
these conditions. The apparent equilibrium solubility of 2FS–
INA was found to be 5.6 times higher than that of pure FS.
Note, however, that the cocrystal undergoes partial conver-
sion into its components on the time-scale of the measure-
ment (24 h), as demonstrated by PXRD, and so this figure is
best regarded as an apparent solubility rather than true equi-
librium solubility. The results of the dissolution and solubil-
ity tests on 2FS–INA and other previously characterised FS
cocrystals are summarised in Table S1 in the ESI.†
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Disorder in the 2FS–INA cocrystal
The 13C spectrum shown in Fig. 4 reflects the fact that there
are two FS molecules and one INA molecule in the asymmet-
ric unit. Most of the carbon atoms are in aromatic environ-
ments causing the peaks to overlap; nevertheless, all the
resolved peaks could be assigned. A combination of experi-
ments were used to accomplish this: 13C dipolar dephasing
to identify the quaternary carbon atoms, 1H-13C heteronuclear
correlation spectra with both long and short contact times,
and also predicted chemical shieldings from CASTEP calcula-
tions (details in the ESI†). No small peaks are observed in the
13C spectrum that could be assigned to the minor-occupied
ring orientation. The broadening observed at 140–143 ppm is
most likely to be due to the proximity of C51 and C52 to the
quadrupolar chlorine atom.36–38 Minor reversible changes are
seen in the 13C spectrum over the temperature range 70 °C to
−50 °C (Fig. S6 in the ESI†), indicative of some dynamics, but
the changes are subtle and hard to link to specific processes.
Dynamic phenyl ring flipping of the INA conformer is not
observed; C1′ and C5′ are observed as distinct peaks at all
temperatures with no evidence of coalescence.
Fig. 5 shows the 15N spectrum and a comparison with cal-
culated 15N chemical shifts for the structures in which the
CASTEP geometry optimisation transferred H11 across the
SSHB to the INA molecule (red) and where H11 was
constrained to the position obtained from single crystal X-ray
diffraction (green). The calculated shieldings were converted
to chemical shifts using δiso = σref − σiso, where σiso is the
CASTEP-calculated shielding value and σref was calculated to
equate the average calculated shift and average experimental
shift39 (σref was −161.7 ppm when H11 was transferred to INA
and −169.0 ppm when H11 was fixed). The experimental
shifts of the four overlapped peaks were estimated by spectral
deconvolution. The experimental shift of N1′ (−116.0 ppm) is
a much better match with the predicted shift range when
H11 is associated with the FS1 molecule and not when pro-
ton transfer had occurred. This shows that H11 is associated
with only FS1 and not the INA (supporting the XRD data),
nor is the position averaged over fast transfer. The CASTEP-
calculated difference in chemical shift upon protonation of
the INA molecule is 36.3 ppm. This is within the experimen-
tal range found for a cocrystal/salt transition. For example,
protonation of INA in a salt with 2,4,6-hydroxybenzoic acid
compared to a cocrystal with 4-hydroxy-3-nitrobenzoic acid
results in a change in chemical shift of −68.8 ppm, while the
15N shift in a 3,5-dinitrobenzoic acid salt compared to a
cocrystal with 4-aminobenzoic acid is 18 ppm.40 Such
changes in chemical shift would be expected to be observed
in the experimental spectrum.
The 15N spectrum is too heavily overlapped to draw con-
clusions about the disorder. On the other hand, the deute-
rium spectrum is less crowded and the disordered
sulphonamide group can be investigated explicitly. As shown
in Fig. 6, the shape of the deuterium spectra clearly change
with temperature, with the bands broadening as the
Fig. 4 13C CPTOSS spectrum (top) and direct-excitation spectrum
(bottom) of 2FS–INA at 8 kHz MAS with carbon atoms labelled as in
Fig. 3.
Fig. 5 15N spectrum of 2FS–INA at 8 kHz MAS. Overlaid are the
calculated 15N shieldings for H11 associated with FS1 (green, top) and
transfer of H11 to INA (red, bottom) where the length of the line
represents the spread of calculated chemical shifts for the different
disorder structures.
Fig. 6 Variable temperature 2H spectra at 10 kHz MAS. The centre-
band of each spectrum is shown on the right. Baselines were corrected
for this figure using the Whittaker Smoother in MestReNova.
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temperature is lowered to −60 °C. The change in linewidth of
the disordered sulphonamide peak was particularly notable
and indicative of the freezing out of a dynamic process at low
temperature (see Fig. S9 of the ESI† for further discussion).
The loss in signal intensity on cooling is due to the noted
broadening and all changes are reversible. A representative
example of the fitting of the spectra to obtain the
quadrupolar parameters is given in Fig. S8 of the ESI.†
Table 2 shows that H12 and H11 are fit with rather differ-
ent CQ values, with the H11 value being markedly low. Chiba,
and others, have reported that reducing the donor–acceptor
distance (rD–A) in a hydrogen bond lowers the CQ
parameter,41–44 which correlates with the finding that
CQĲH11) < CQĲH12); rD–AĲH11) is 2.546 Å while rD–AĲH12) is
2.619 Å by single crystal XRD. Most studies of HBs in molecu-
lar solids typically include a variety of types of hydrogen
bonds with different strengths, which limits the use of the
data in determining quantitative trends in CQ with structural
parameters.43 While quadrupolar parameters have been
quantitatively correlated with hydrogen bond geometry indi-
vidual cases, such as an isolated molecule containing a
CO⋯HO hydrogen bond, in which η was shown to be more
sensitive to bond angles than rD–A,
45 these are not directly rel-
evant to H11 which is in an N⋯HO hydrogen bond.
The CASTEP-calculated CQ and η values for H12 and H11
are comparable with the experimental fits. However, the cal-
culated CQ of the disordered sulphonamide site is around 2.5
times larger than the values determined from the −50 °C
data. This can only be explained in terms of extensive dynam-
ics. NH2 dynamics have previously been studied in pure FS
by monitoring 1H relaxation times and were described in
terms of hindered NH2 jumps that were rapid at ambient
temperature.46 Estimating the underlying quadrupolar
parameters from the average of the CASTEP-calculated
parameters, i.e. CQ = 222 kHz, η = 0.16, and averaging the ten-
sor over a 112° jump (corresponding to exchange of the two
hydrogens of the NH2) gives values which are still too high,
CQ = 112 kHz, η = 0.66. Values that are more consistent with
the experimental results are obtained if the tensor is aver-
aged successively over two jump motions. As an illustrative
example, jumps of both 112° and 40° give CQ = 89 kHz, η =
0.57 and jumps of both 112° and 30° give CQ = 100 kHz, η =
0.61. This is consistent with the magnitude of the angle mea-
sured crystallographically between the two disordered
sulphonamide positions. The quadrupolar parameters are
also affected by high frequency librational motions,47 and the
actual atomic motion at ambient temperature will be more
complex than instantaneous jumps between discrete sites.
We can still conclude that the observed deuterium
quadrupolar parameters are consistent with rapid rotations
between the two orientations of the sulphonamide observed
by XRD plus exchange of the hydrogen sites on the NH2, both
at a relatively high frequency (at least 100 s kHz at ambient
temperature). It should also be noted that the dynamic
sulphonamide groups are relatively close to each other
ĲrNH2−NH2 between sulphonamide groups in two orientations
of FS1 = 2.452 Å), and so the motion may be further compli-
cated by correlation between the orientations.
Complementary information is provided from the temper-
ature dependence of the 2H T1 relaxation times. The relaxa-
tion data was fitted (see Fig. 7) to direct calculations of the
2H relaxation rate under MAS using a simple two-site jump
model48 and the CASTEP-calculated CQ of 222 kHz. Using an
Arrhenius-type model for the temperature dependence of the
jump correlation time with temperature, τc = τ0 expĲEa/kT), the
fit shown corresponds to log10Ĳτ0/s) = −12.0 ± 0.1, Ea = 16.7 ±
0.7 kJ mol−1 and a jump angle of 26.5 ± 0.5°. The one stan-
dard deviation errors bars are based on an averaged uncer-
tainty of the fitted T1 values of 0.7 ms. Note that including a
correction for sample heating due to MAS results in a slight
increase in the fitted Ea (from 14.9 kJ mol
−1) and only
Table 2 Fitted 2H quadrupolar coupling parametersa at three temperatures plus average calculated values
Deuterium site
−50 °C 20 °C 40 °C CASTEP averageb
CQ/kHz η CQ/kHz η CQ/kHz η CQ/kHz η
Sulphonamide 88.4(6) 0.51(2) 87.1(2) 0.417(6) 87.8(2) 0.421(7) 222 0.16
H12 170(2) 0.22(5) 161(2) 0.34(4) 168(2) 0.26(5) 138 0.16
H11c 68.8(5) 0.39(3) 78.9(5) 0.34(3) 81.0(9) 0.32(5) 48 0.52
a One-standard deviation uncertainties are given in parentheses, although these are likely to be underestimated. The −60 °C spectrum could
not be fitted satisfactorily due to the broadening of the sulphonamide and H12 peaks. b Full details of CASTEP-calculated values are given in
Table S4 in the ESI. c Structures showing proton transfer of H11 are not included in the CASTEP average.
Fig. 7 Sulphonamide 2H T1 relaxation time constant as a function of
temperature fit to a two-site jump model with an Arrhenius-type tem-
perature dependence of the jump rate. Temperatures include a correc-
tion of +15 °C for sample heating due to MAS.
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marginal effect on the other fitting parameters. These values
should, however, be treated with caution since the actual
molecular motion is likely to be more complex. The non-zero
asymmetry of the 2H site was not accounted for since the
expressions of Torchia and Szabo49 assume η = 0, but this will
not have a significant impact. This fitting corresponds to a τc
at 298 K of 86 × 10−11 s, and so an effective jump rate, 1/τc, of
1.2 GHz, consistent with observing an averaged CQ in the
2H spec-
trum. The fitted activation barrier is somewhat smaller than the
activation energy of the hindered NH2 jumps measured in pure
FS (31 kJ mol−1),46 but is consistent with essentially the same
basic process being involved. The estimated jump rate at
−60 °C is 80 MHz and it is likely that the broadening of the
2H spectrum in Fig. 6 at low temperature is associated with
freezing out some aspect of the sulphonamide dynamics.
The 13C CPTOSS spectrum in Fig. 4 is too strongly
overlapped to provide clear conclusions about the ring disor-
der, and 2D 1H-13C HETCOR and 1H DQ/SQ experiments were
also inconclusive (see ESI† for more details). However, in a
direct excitation experiment with a short recycle delay to
select only dynamic carbon sites only the carbon atoms of
both furan rings are observed (bottom of Fig. 4). This indi-
cates that both furan rings are dynamically disordered.
As anticipated from the direct excitation spectrum, the 13C
T1 relaxation times for the furan ring carbon atoms are sig-
nificantly shorter than those of the other carbon sites (see
Table S5 of the ESI† for the full data). Since T1 relaxation of
is driven by motion on the order of the NMR frequency of
the spins involved, this implies that these carbon sites are
dynamic at rates of the order of 125 MHz at ambient temper-
ature. The magnitude and the temperature dependence of
the 13C T1 times, Fig. 8, is similar between the two furan
rings, suggesting that similar processes are involved. The var-
iable temperature data can be fitted using expressions for
dipolar relaxation in solid sample due to rotational diffusion
on a cone49 to yield the parameters given in Table 3.
Given the simple model used, the agreement between
motional parameters for the carbon atoms of the same ring
is quite satisfactory. The differences in parameters between
the rings are generally not statistically significant, although
the cone angle for C12 is arguably larger (corresponding to a
greater motional amplitude) in FS2 compared to FS1.
In the structure determination from single crystal X-ray
diffraction, resolved electron density in the difference Fourier
map prompted the modelling of the FS2 ring using split
atomic sites and isotropic thermal parameters, while the FS1
furan ring was modelled with single atomic sites and aniso-
tropic atomic displacement parameters (ADPs). As seen in
Fig. 3, the resulting ADPs are slightly elongated along one
axis, suggesting the presence of small amplitude dynamics. It
is important to note, however, that an essentially equally
good fit to the experimental XRD data can be obtained using
single sites and anisotropic ADPs to describe both furan
rings, as shown in Fig. S11.† In this fit, the ring disorder on
FS1 and FS2 appears very similar, with only a subtle differ-
ence in amplitude. In other words, in this case a single-
temperature XRD experiment was unable to distinguish
between small and large amplitude re-orientations of the
ring. As discussed above, the calculated 13C chemical shifts
are also not particularly sensitive to the orientation of the
ring, and it is the relaxation data that strongly suggests that
both FS1 and FS2 are likely to be undergoing similar small
amplitude motion.
Conclusions
The pharmaceutically relevant properties of the furosemide–
isonicotinamide 2 : 1 cocrystal, 2FS–INA, have been investi-
gated. The intrinsic dissolution rate of 2FS–INA was the same
as that of commercial FS, and its apparent equilibrium solu-
bility was 5.6 times higher. Like most other characterised
furosemide cocrystals, however, 2FS–INA underwent a partial
conversion into its components over 24 hours of the solubil-
ity measurement. All reported FS cocrystals, and in this paper
2FS–INA cocrystal, have much higher apparent solubility
than FS.
Three specific questions concerning the extensive struc-
tural disorder in the 2FS–INA cocrystal, posed by the previous
single crystal low-temperature X-ray diffraction study, have
been investigated using variable-temperature solid-state
nuclear magnetic resonance spectroscopy supported by first
Fig. 8 The temperature dependence of the 13C T1 relaxation times for
the furan rings on FS1 and FS2. Temperatures include a correction of
+10 °C for sample heating due to MAS.
Table 3 Parameters describing the dynamics at the carbon atoms on the
two furan rings from 13C T1 measurements
a
Ea/kJ mol
−1 log τ0 Cone angle/degrees
FS1 C121 20(2) −12.7Ĳ3) 19.8(5)
C101 22(1) −13.3Ĳ2) 21.6(4)
FS2 C122 25(1) −13.7Ĳ2) 31.9(9)
C102/C112 22(1) −13.2Ĳ2) 21.3(4)
a 13C T1 data for C111 could not be satisfactorily fit due to the low
signal intensity.
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principles calculations: the nature of the disorder of the
sulphonamide group, the furan ring, and the potential pro-
ton disorder in a short strong hydrogen bond.
No evidence for dynamic proton transfer in the short
OH⋯N hydrogen bond was found. The disorder on the
sulphonamide group could be readily probed using variable
temperature 2H experiments and was found to be consistent
with fast exchange of the NH2 protons as well as a rotation of
the whole sulphonamide group about the C–S bond. The
empirical activation energy for this process is estimated to be
17 kJ mol−1, although the motion is expected to be more
complex than a simple two-site jump. A direct excitation 13C
spectrum showed that the carbon atoms on the furan rings
of both unique FS molecules had short relaxation times, and
13C spin–lattice relaxation times measured as a function of
temperature provided estimates for the energy barriers to
rotation of the two furan rings, which were found to be the
same within experimental uncertainty.
In general terms, this work illustrates the complementar-
ity of diffraction and NMR in studying structural disorder.
While disorder can be readily observed by diffraction
methods and in certain cases some insight into its nature
can be gained from careful variable-temperature experiments
analysed using the translation-libration-screw (TLS) formal-
ism,50 the quality of diffraction data generally deteriorates as
the temperature is raised. In contrast, dynamic disorder at
ambient temperatures often simplifies NMR spectra by sharp-
ening lines and shortening relaxation times. Hence NMR
aided by DFT calculations provides a straightforward way to
establish the nature of disorder and provide quantitative
information on the relevant processes.
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